SPL + Aspen - presenting BV-gel in Mar-2017., page-2

Thanks for posting Idean so they will have it on the shelf by then at least here is a paste for others as you have to find it in the conf brochure programme
Education Session: Fleurstat™ BV gel - an Australian innovation in the Treatment of Bacterial Vaginosis Bacterial Vaginosis (BV) is the most common vaginal infection worldwide. Untreated it can cause miscarriage, infertility as well as increased risk of HIV. Existing therapeutic options for BV (antibiotics and pH modifiers) are inadequate due to lack of specificity, low efficacy and poor tolerability. Based on technology originating from CSIRO. Fleurstat™ BV vaginal gel specifically targets the bacteria that cause BV, is clinically proven to be effective, well tolerated, is available over-the-counter and is an ideal therapeutic option for the treatment of BV and its symptoms. Speakers: Dr Michael Flynn; Obstetrician & Gynaecologist; Dr Jackie Fairley, Chief Executiv